Patent details

EP3286204 Title: METHOD OF MONOMERISATION OF RECOMBINANT ANTIBODY MOLECULES

Basic Information

Publication number:
EP3286204
PCT Application Number:
EP2016059051
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP167198241
PCT Publication Number:
WO2016170138
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHOD OF MONOMERISATION OF RECOMBINANT ANTIBODY MOLECULES
French Title of Invention:
PROCÉDÉ DE MONOMÉRISATION DE MOLÉCULES D'ANTICORPS RECOMBINÉES
German Title of Invention:
VERFAHREN ZUR MONOMERISIERUNG REKOMBINANTER ANTIKÖRPERMOLEKÜLE
SPC Number:

Dates

Filing date:
22/04/2016
Grant date:
18/11/2020
EP Publication Date:
28/02/2018
PCT Publication Date:
27/10/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/11/2020
EP B1 Publication Date:
18/11/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/04/2021
Expiration date:
22/04/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/11/2020
 
 

Name:
UCB Biopharma SRL
Address:
Allé de la Recherche 60, 1070 Brussels, Belgium (BE)

Inventor

1

Name:
LE PAGE, Christopher John
Address:
United Kingdom (GB)

2

Name:
HEYWOOD, Sam Philip
Address:
United Kingdom (GB)

3

Name:
HANIF, Razwan
Address:
United Kingdom (GB)

4

Name:
WILD, Gavin Barry
Address:
United Kingdom (GB)

Priority

Priority Number:
201506870
Priority Date:
22/04/2015
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
A61K 39/395; C07K 1/113; C07K 16/18; C07K 16/28;

Publication

European Patent Bulletin

Issue number:
202047
Publication date:
18/11/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages